RT Journal Article SR Electronic T1 Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia JF Haematologica JO Haematologica FD Ferrata Storti Foundation SP e514 OP e518 DO 10.3324/haematol.2018.191361 VO 103 IS 11 A1 Ravandi, Farhad A1 Ritchie, Ellen K. A1 Sayar, Hamid A1 Lancet, Jeffrey E. A1 Craig, Michael D. A1 Vey, Norbert A1 Strickland, Stephen A. A1 Schiller, Gary J. A1 Jabbour, Elias A1 Pigneux, Arnaud A1 Horst, Heinz-August A1 Récher, Christian A1 Klimek, Virginia M. A1 Cortes, Jorge E. A1 Carella, Angelo-Michele A1 Egyed, Miklos A1 Krug, Utz A1 Fox, Judith A. A1 Craig, Adam R. A1 Ward, Renee A1 Smith, Jennifer A. A1 Acton, Gary A1 Kantarjian, Hagop M. A1 Stuart, Robert K. YR 2018 UL http://www.haematologica.org/content/103/11/e514.abstract